๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Joseph Schwartz

Stock Analyst at Leerink Partners

(4.97)
# 93
Out of 5,189 analysts
1286
Total ratings
53.2%
Success rate
31.5%
Average return

Stocks Rated by Joseph Schwartz

IRulya Therapeutics
Nov 19, 2026
Reiterated: Buy
Price Target: $68
Current: $39.88
Upside: +70.51%
Eloxx Pharmaceuticals
Nov 17, 2026
Reiterated: Buy
Price Target: $32
Current: $10.69
Upside: +199.35%
Pharvaris
Nov 16, 2026
Reiterated: Buy
Price Target: $65
Current: $31.28
Upside: +107.80%
uniQure
Nov 16, 2026
Reiterated: Buy
Price Target: $70
Current: $19.35
Upside: +261.76%
Ascendis Pharma
Nov 13, 2026
Reiterated: Buy
Price Target: $305 → $326
Current: $252.73
Upside: +28.99%
PepGen
Nov 10, 2026
Reiterated: Buy
Price Target: $10 → $16
Current: $3.78
Upside: +323.28%
Mirum Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $154 → $140
Current: $96.13
Upside: +45.64%
Ultragenyx Pharmaceutical
Nov 5, 2026
Reiterated: Buy
Price Target: $33
Current: $16.48
Upside: +100.24%
Solid Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $20
Current: $6.25
Upside: +220.00%
Wave Life Sciences
Oct 29, 2026
Rated: Buy
Price Target: $25 → $10
Current: $2.56
Upside: +290.63%
Reiterated: Buy
Price Target: $28.69
Current: $8.24
Upside: +248.22%
Reiterated: Buy
Price Target: n/a
Current: $39.91
Upside: -
Upgraded: Buy
Price Target: $80
Current: $10.72
Upside: +646.27%
Downgraded: Hold
Price Target: $24 → $4
Current: $3.69
Upside: +8.40%
Reiterated: Hold
Price Target: $60 → $62
Current: $60.41
Upside: +2.63%
Upgraded: Buy
Price Target: $1 → $9
Current: $5.08
Upside: +77.17%
Initiated Coverage: Buy
Price Target: $25
Current: $6.92
Upside: +261.27%
Reiterated: Buy
Price Target: $160 → $120
Current: $38.00
Upside: +215.79%
Reiterated: Buy
Price Target: $50
Current: $31.37
Upside: +59.39%
Reiterated: Hold
Price Target: $15
Current: $13.33
Upside: +12.53%
Reiterated: Buy
Price Target: n/a
Current: $47.00
Upside: -
Reiterated: Hold
Price Target: n/a
Current: $1.04
Upside: -
Reiterated: Buy
Price Target: $8 → $2
Current: $0.26
Upside: +669.23%
Downgraded: Hold
Price Target: $12 → $16
Current: $14.70
Upside: +8.84%
Upgraded: Buy
Price Target: $5 → $14
Current: $9.02
Upside: +55.21%
Initiated Coverage: Buy
Price Target: $115
Current: $69.00
Upside: n/a
Reiterated: Hold
Price Target: $54
Current: $56.42
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $141.33
Upside: n/a
Reiterated: Buy
Price Target: $25
Current: $3.14
Upside: n/a
Reiterated: Hold
Price Target: $1
Current: $0.9602
Upside: n/a
Reiterated: Hold
Price Target: $10
Current: $2.70
Upside: n/a
Reiterated: Hold
Price Target: $14
Current: $314.32
Upside: n/a
Downgraded: Hold
Price Target: $150 → $30
Current: $6.14
Upside: n/a
Reiterated: Hold
Price Target: $40 → $34
Current: $26.58
Upside: n/a
Reiterated: Buy
Price Target: $30
Current: $121.40
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $435.64
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $16.97
Upside: n/a
Downgraded: Hold
Price Target: $31 → $4
Current: $46.53
Upside: n/a
Downgraded: Sell
Price Target: n/a
Current: $310.53
Upside: n/a
Reiterated: Buy
Price Target: $54.37
Current: $257.92
Upside: n/a
Downgraded: Hold
Price Target: $5 → $30
Current: $0.287
Upside: n/a
Initiated Coverage: Buy
Price Target: $37 → $23
Current: $10.00
Upside: n/a
Reiterated: Buy
Price Target: $10 → $12
Current: $1.04
Upside: n/a
Reiterated: Hold
Price Target: $121 → $126
Current: $554.73
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $9.02
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $0.0708
Upside: n/a
Reiterated: Buy
Price Target: $12 → $14
Current: $1.24
Upside: n/a
Reiterated: Buy
Price Target: $24
Current: $0.7774
Upside: n/a
Reiterated: Buy
Price Target: $664
Current: $920.69
Upside: n/a
Reiterated: Buy
Price Target: $512 → $425
Current: $249.59
Upside: n/a
Initiated Coverage: Buy
Price Target: $20 → $8
Current: $50.78
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $10.57
Upside: n/a